Different nucleos(t)ide analogs in resected hepatitis B virus-associated hepatocellular carcinoma: a systematic review. [PDF]
Qiu H, Zhang Y, Xu F, Xue S.
europepmc +1 more source
Investigation of the long-term effects of high-potency antiviral agents on aspartate aminotransferase-to-platelet ratio index and fibrosis index based on four factors: five-year outcomes in hepatitis B e-antigen-negative chronic hepatitis B patients. [PDF]
Arslan M, Cavnar AM, Çetin Ş.
europepmc +1 more source
Effects of Non-Alcoholic Fatty Liver Disease on Baseline Histology and 96-Week Entecavir Response in Treatment-Naïve Chronic Hepatitis B. [PDF]
Gu X +5 more
europepmc +1 more source
Serum type III procollagen, procollagen V, tumour necrosis factor-a, interleukin-6 in liver cirrhosis after antiviral treatment. [PDF]
Li W, Liu X, Bi F.
europepmc +1 more source
Effect of antiviral therapy on 3-year recurrence and prognosis of hepatocellular carcinoma after curative radiofrequency ablation. [PDF]
Xu BG +6 more
europepmc +1 more source
Multidisciplinary management of thyroid eye disease (TED) in patients with latent tuberculosis or chronic hepatitis B. [PDF]
Vekinis JS +6 more
europepmc +1 more source
Panduratin A from Boesenbergia rotunda suppresses hepatitis B virus by targeting HNF1α and synergizing with antiviral agents. [PDF]
Thongsri P +8 more
europepmc +1 more source
Effectiveness and safety of tralokinumab in a patient with severe atopic dermatitis and hepatitis B virus. [PDF]
Olivares-Guerrero M +3 more
europepmc +1 more source
Long-Term Outcomes of Patients Who Receive a Liver Transplant for Hepatitis B With Limited Use of Hepatitis B Immunoglobulin. [PDF]
Roldan GA, Loon E, Lake J, Lim N.
europepmc +1 more source

